KKR Genetic Disorder L.P. - Insider Trading & Ownership

Entity
Company
Location
C/O Kohlberg Kravis Roberts & Co. L.P., 9 West 57 Th Street, Suite 4200, New York, NY
Summary
The estimated value of insider holdings of KKR Genetic Disorder L.P. is at least $650M dollars as of September 17, 2024. KKR Genetic Disorder L.P. is the 10%+ Owner of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $650M.
All Insider Reports
All Insider Reports

Ownership of KKR Genetic Disorder L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BBIO BridgeBio Pharma, Inc. 10%+ Owner $650M -$149M -18.7% Sep 13, 2024

Insider Transactions Reported by KKR Genetic Disorder L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.